29 April 2019 - It seems fitting that President Trump — who describes himself as a master negotiator — wants a big, bold move to lower prescription drug prices by allowing the government to directly negotiate with pharmaceutical companies.

If a deal emerged between the White House and House Speaker Nancy Pelosi on allowing such negotiations by Medicare — long anathema to Republicans, who view such a move as price fixing — it would be because the president wasn’t satisfied with a set of smaller-bore ideas being pursued on Capitol Hill and by his Department of Health and Human Services.

Trump has promised numerous times to slash drug prices. As he looks ahead to his reelection effort, achieving something as major as direct negotiations between Medicare and drug companies could be just the win he’s looking for — especially considering the idea is favoured by a large majority of Americans.

Read Washington Post article